Science 2025 Marks Landmark Advances in Incretin Therapy for Diabetes The year 2025 has emerged as a pivotal time for incretin-based therapies, particularly GLP-1 receptor agonists, in the treatment of diabetes and related conditions.... Editorial11 hours ago